Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant catatonia

K L Philbrick1, T A Rummans

  • 1Section of Psychiatry, Mayo Clinic, Rochester, Minnesota 55905.

The Journal of Neuropsychiatry and Clinical Neurosciences
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

This review clarifies malignant catatonia, emphasizing the need to recognize non-neuroleptic causes for timely, life-saving treatment of this rare but serious syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Religious involvement, spirituality, and medicine: implications for clinical practice.

Mayo Clinic proceedings·2002
Same author

The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2001
Same author

ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.

The journal of ECT·2001
Same author

Why do patients have orthostatic symptoms in POTS?

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2001
Same author

Successful electroconvulsive therapy in an elderly man with severe thrombocytopenia: case report and literature review.

The journal of ECT·2001
Same author

ECT and automatic internal cardioverter-defibrillator.

The journal of ECT·2001
Same journal

The Neuropsychiatric Phenotype of Klüver-Bucy Syndrome: A Systematic Review of Reported Cases.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

Diffusion Tensor Imaging Correlates of Financial Capacity Instrument-Short Form Completion Time in Mild Cognitive Impairment.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

A 3-Week Intensive Outpatient Program for Patients With Persistent Neuropsychiatric Symptoms After Remote TBI.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

Outcomes of Integrated Practice Unit Treatment for Mild Traumatic Brain Injury and Co-occurring Conditions Among Veterans.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

Case Study 12: A 57-Year-Old Man With Seizures, Paranoid Psychosis, and Catatonia.

The Journal of neuropsychiatry and clinical neurosciences·2026
Same journal

Rates of Comorbid Psychiatric Conditions Among Adults With Hydrocephalus at a Hydrocephalus Specialty Center.

The Journal of neuropsychiatry and clinical neurosciences·2026
See all related articles

Area of Science:

  • Psychiatry
  • Neurology

Background:

  • Catatonia is a complex neuropsychiatric syndrome with a history spanning over a century.
  • Malignant catatonia, a severe subtype, presents significant diagnostic and therapeutic challenges.

Observation:

  • Recent literature (1986-1991) primarily focuses on neuroleptic-induced malignant catatonia.
  • Non-neuroleptic causes of malignant catatonia are less frequently reported, potentially delaying diagnosis.
  • The authors present 5 cases of psychiatric malignant catatonia from their institution.

Findings:

  • A revised nomenclature for catatonia is proposed to improve understanding.
  • Malignant catatonia, though infrequent, requires prompt recognition due to its life-threatening potential.
  • Current understanding and treatment are hindered by insufficient attention to non-neuroleptic-induced forms.

Related Experiment Videos

Implications:

  • Enhanced recognition of diverse malignant catatonia etiologies is crucial for effective clinical management.
  • Further research into non-neuroleptic-induced malignant catatonia is needed.
  • Establishing a clearer diagnostic framework can improve patient outcomes for this severe syndrome.